Valuation: PolyPeptide Group AG

Market Cap 1.55B 1.8B 1.45B 1.33B 2.5B 171B 2.54B 17.02B 6.68B 85.67B 6.74B 6.6B 283B P/E 2026 *
56.7x
P/E 2027 * 31.2x
Enterprise Value 1.65B 1.91B 1.55B 1.42B 2.67B 182B 2.71B 18.13B 7.12B 91.26B 7.18B 7.03B 302B EV / Sales 2026 *
3.36x
EV / Sales 2027 * 2.96x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.07%
1 week+0.34%
Current month+0.34%
1 month-6.59%
3 months+11.55%
6 months+64.92%
Current year+68.39%
1 week 43.85
Extreme 43.85
44
1 month 41.55
Extreme 41.55
47.6
Current year 23.1
Extreme 23.1
50.1
1 year 21.8
Extreme 21.8
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
147.4
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 2023-04-11
Director of Finance/CFO 54 2024-01-01
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 2005-12-31
Chairman 69 2021-03-31
Director/Board Member 62 2020-12-31
Date Insider Type Main position Quantity % Market Cap.
11/13/23 Buy 2,500 0.0075%
10/12/23 Buy 159,959 0.4829%
4/6/23 Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.34%+102.07%+91.92% 1.8B
-0.52%+3.21%+89.52%+125.32% 1,057B
+0.88%+1.13%+49.56%+49.79% 625B
+0.89%-1.95%+24.23%+63.19% 435B
+0.71%+3.87%+49.07%+38.29% 363B
+0.64%-0.49%+33.94%+38.94% 296B
+0.39%-5.83%+8.92%+6.39% 249B
+1.51%+6.69%+42.58%+58.47% 222B
+3.92%-0.46%-5.56%-51.70% 209B
+1.80%+2.30%+11.56%+66.16% 165B
Average +1.02%+0.88%+40.59%+48.68% 362.26B
Weighted average by Cap. +0.66%+1.33%+48.75%+63.87%

Financials

2026 *2027 *
Net sales 492M 569M 459M 421M 793M 54.12B 805M 5.39B 2.12B 27.13B 2.14B 2.09B 89.68B 568M 656M 530M 486M 915M 62.48B 930M 6.22B 2.44B 31.32B 2.47B 2.41B 104B
Net income 23.54M 27.21M 21.98M 20.16M 37.93M 2.59B 38.53M 258M 101M 1.3B 102M 99.95M 4.29B 43.85M 50.69M 40.95M 37.56M 70.65M 4.82B 71.77M 480M 189M 2.42B 190M 186M 7.99B
Net Debt 101M 117M 94.75M 86.92M 163M 11.16B 166M 1.11B 436M 5.6B 440M 431M 18.5B 130M 150M 121M 111M 209M 14.27B 212M 1.42B 558M 7.15B 563M 551M 23.64B
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,440
Date Price Change Volume
26-08-07 CHF 43.95 0.00% 90,058
26-08-06 CHF 43.95 +0.23% 102,855
26-08-05 CHF 43.85 -0.11% 76,951
26-08-04 CHF 43.90 +0.11% 146,224
26-08-03 CHF 43.85 +0.11% 77,627
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
47.06EUR
Average target price
41.80EUR
Spread / Average Target
-11.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PPGN Stock